Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy
- PMID: 20937924
- DOI: 10.1001/archinternmed.2010.355
Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy
Abstract
Background: Polypharmacy and inappropriate medication use is a problem in elderly patients, who are more likely to experience adverse effects from multiple treatments and less likely to obtain the same therapeutic benefit as younger populations. The Good Palliative-Geriatric Practice algorithm for drug discontinuation has been shown to be effective in reducing polypharmacy and improving mortality and morbidity in nursing home inpatients. This study reports the feasibility of this approach in community-dwelling older patients.
Methods: The Good Palliative-Geriatric Practice algorithm was applied to a cohort of 70 community-dwelling older patients to recommend drug discontinuations. Success rates of discontinuation, morbidity, mortality, and changes in health status were recorded.
Results: The mean (SD) age of the 70 patients was 82.8 (6.9) years. Forty-three patients (61%) had 3 or more and 26% had 5 or more comorbidities. The mean follow-up was 19 months. Participants used a mean (SD) of 7.7 (3.7) medications. Protocol indicated that discontinuation was recommended for 311 medications in 64 patients (58% of drugs; mean [SD], 4.4 [2.5] drugs per patient overall, 4.9 per patient who had discontinuation). Of the discontinued drug therapies, 2% were restarted because of recurrence of the original indication. Taking nonconsent and failures together, successful discontinuation was achieved in 81%. Ten elderly patients (14%) died after a mean follow-up of 13 months, with the mean age at death of 89 years. No significant adverse events or deaths were attributable to discontinuation, and 88% of patients reported global improvement in health.
Conclusions: It is feasible to decrease medication burden in community-dwelling elderly patients. This tool would be suitable for larger randomized controlled trials in different clinical settings.
Comment in
-
Reducing drugs in older adults is more.Arch Intern Med. 2011 May 9;171(9):868-9. doi: 10.1001/archinternmed.2011.207. Arch Intern Med. 2011. PMID: 21555673 No abstract available.
-
Reducing polypharmacy: is hospitalization the right time?Arch Intern Med. 2011 May 9;171(9):869; author reply 870. doi: 10.1001/archinternmed.2011.208. Arch Intern Med. 2011. PMID: 21555674 No abstract available.
Similar articles
-
The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people.Isr Med Assoc J. 2007 Jun;9(6):430-4. Isr Med Assoc J. 2007. PMID: 17642388
-
[Remote drug-review for better use of pharmaceuticals among the elderly].Lakartidningen. 2005 Apr 11-17;102(15):1143, 1145-6, 1149. Lakartidningen. 2005. PMID: 15892348 Swedish.
-
Sex differences in inappropriate drug use: a register-based study of over 600,000 older people.Ann Pharmacother. 2009 Jul;43(7):1233-8. doi: 10.1345/aph.1M147. Epub 2009 Jul 7. Ann Pharmacother. 2009. PMID: 19584395
-
Polypharmacy in the elderly: maximizing benefit, minimizing harm.Crit Care Nurs Q. 2008 Jan-Mar;31(1):40-5. doi: 10.1097/01.CNQ.0000306395.86905.8b. Crit Care Nurs Q. 2008. PMID: 18316935 Review.
-
[Pitfalls of polypharmacy, particularly in the elderly].Bull Mem Acad R Med Belg. 2006;161(6):408-21; discussion 422-4. Bull Mem Acad R Med Belg. 2006. PMID: 17288274 Review. French.
Cited by
-
Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review.J Clin Med. 2024 Oct 21;13(20):6283. doi: 10.3390/jcm13206283. J Clin Med. 2024. PMID: 39458232 Free PMC article. Review.
-
Development of a Predictive Model for Potentially Inappropriate Medications in Older Patients with Cardiovascular Disease.Drugs Aging. 2024 Aug;41(8):675-683. doi: 10.1007/s40266-024-01127-8. Epub 2024 Jun 27. Drugs Aging. 2024. PMID: 38937426 Free PMC article.
-
Optimizing clinical outcomes in polypharmacy through poly-de-prescribing: a longitudinal study.Front Med (Lausanne). 2024 Apr 30;11:1365751. doi: 10.3389/fmed.2024.1365751. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38745740 Free PMC article.
-
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study.Int J Clin Pharm. 2024 Aug;46(4):889-898. doi: 10.1007/s11096-024-01723-z. Epub 2024 Apr 20. Int J Clin Pharm. 2024. PMID: 38642248
-
Central nervous system medication use around hospitalization.J Am Geriatr Soc. 2024 Jun;72(6):1707-1716. doi: 10.1111/jgs.18915. Epub 2024 Apr 10. J Am Geriatr Soc. 2024. PMID: 38600620
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
